Dongsung Pharmaceutical Appoints Experienced Pharma Executive Choi Yong-seok as New CEO
Dongsung Pharmaceutical appointed Choi Yong-seok as its new CEO effective April 14, 2026, subject to court approval.
The new CEO has extensive experience at major pharmaceutical companies including AstraZeneca, Takeda, and Hanmi Pharmaceutical.
Along with the CEO appointment, four outside directors and two non-executive directors were newly appointed to strengthen governance and expertise.
[AI Summary]The appointment of a new CEO and board members enhances management stability and expertise but does not directly impact short-term share value, warranting a neutral assessment.
KOSPI Filing Information
Filing: Change Of Representative Director (Representative Executive Officer) (Notice Disclosure)